Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Biotech
Cash-strapped Alopexx reignites plans to go public via $30M IPO
Alopexx has resuscitated plans for a public listing as the biotech seeks urgently needed funds to advance its pipeline.
James Waldron
Jun 27, 2026 8:16am
Fierce Pharma
PwC projects continued growth for rest of 2026, fueled by M&A
Jun 17, 2026 5:00am
Biotech IPOs here to stay after another record-breaking listing
Jun 12, 2026 11:00am
Kardigan plans to bring in cozy $320M haul from upcoming IPO
Jun 11, 2026 8:14am
Parabilis’ upsized $670M IPO breaks new record for biotechs
Jun 10, 2026 4:36am
Parabilis ups planned IPO haul to record-setting $637M
Jun 9, 2026 10:22am
